Guangdong Weiren Meditech Co., Ltd., founded in 2017, is a high-growth technology enterprise located in China that specializes in the research and development of high-end optical medical equipment for ophthalmology and committed to establishing a complete ophthalmic imaging product layout.
The core R&D team of the company includes senior experts in optical and system design, as well as software algorithm research. Most of them are Ph.D.s from internationally renowned research institutions. Weiren Meditech is an innovation team imported by the Pearl River Talent Program and also the engineering research center for intelligent medical imaging equipment in ophthalmology in Guangdong Province, China.
Weiren Meditech has developed Velite optical coherence tomography system(OCT) with a ultra-high line speed of up to 120kHz/second and an imaging depth of ≥3.5mm(intra-tissue). With the comprehensive optimization of the OCT algorithm, The imaging performance of VELITE OCT has reached the world-leading level in spectral domain OCT.
Weiren Meditech is also developing Al technology for ophthalmology, researching high-quality imaging systems based on artificial intelligence technology and intelligent diagnosis cloud platforms. The R&D team of Weiren Meditech achieved outstanding results at MICCAI 2022, where they stood out from more than 400 teams from around the world. They ranked first in total score for ophthalmology, first in glaucoma recognition based on OCT images, and second in retinal layer segmentation based on OCT.
Weiren Medical will serve the entire process of eye health by empowering devices and doctors through AI technology, establishing an intelligent system for abnormal screening and disease diagnosis of eye diseases.
